278 related articles for article (PubMed ID: 15887642)
1. [New investigations in suspected Creutzfeldt-Jakob disease. Analysis of 14-3-3 protein and T-tau in cerebrospinal fluid for safer diagnosis].
Zetterberg H; Hammarin AL; Nilsson P; Andersson E; Lind B; Blennow K
Lakartidningen; 2005 Mar 21-Apr 3; 102(12-13):956-8, 960-1. PubMed ID: 15887642
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review.
Koscova S; Zakova Slivarichova D; Tomeckova I; Melicherova K; Stelzer M; Janakova A; Kosorinova D; Belay G; Mitrova E
Mol Neurobiol; 2017 Oct; 54(8):5919-5927. PubMed ID: 27665282
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease.
Blennow K; Johansson A; Zetterberg H
Int J Mol Med; 2005 Dec; 16(6):1147-9. PubMed ID: 16273298
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry.
Skillbäck T; Rosén C; Asztely F; Mattsson N; Blennow K; Zetterberg H
JAMA Neurol; 2014 Apr; 71(4):476-83. PubMed ID: 24566866
[TBL] [Abstract][Full Text] [Related]
5. Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease.
Llorens F; Zafar S; Ansoleaga B; Shafiq M; Blanco R; Carmona M; Grau-Rivera O; Nos C; Gelpí E; Del Río JA; Zerr I; Ferrer I
Neuropathol Appl Neurobiol; 2015 Aug; 41(5):631-45. PubMed ID: 25134744
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt-Jakob disease: a comparative prospective study with 14-3-3.
Llorens F; Villar-Piqué A; Hermann P; Schmitz M; Goebel S; Waniek K; Lachmann I; Zerr I
J Neurol; 2020 Feb; 267(2):543-550. PubMed ID: 31701333
[TBL] [Abstract][Full Text] [Related]
7. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.
Lattanzio F; Abu-Rumeileh S; Franceschini A; Kai H; Amore G; Poggiolini I; Rossi M; Baiardi S; McGuire L; Ladogana A; Pocchiari M; Green A; Capellari S; Parchi P
Acta Neuropathol; 2017 Apr; 133(4):559-578. PubMed ID: 28205010
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal Fluid Levels of 14-3-3 Gamma: What Does It Tell Us About Sporadic Creutzfeldt-Jakob Disease?
Humpel C; Benke T
Pharmacology; 2017; 100(5-6):243-245. PubMed ID: 28743115
[TBL] [Abstract][Full Text] [Related]
9. Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease.
Satoh K; Shirabe S; Tsujino A; Eguchi H; Motomura M; Honda H; Tomita I; Satoh A; Tsujihata M; Matsuo H; Nakagawa M; Eguchi K
Dement Geriatr Cogn Disord; 2007; 24(3):207-12. PubMed ID: 17690553
[TBL] [Abstract][Full Text] [Related]
10. Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease.
Dorey A; Tholance Y; Vighetto A; Perret-Liaudet A; Lachman I; Krolak-Salmon P; Wagner U; Struyfs H; De Deyn PP; El-Moualij B; Zorzi W; Meyronet D; Streichenberger N; Engelborghs S; Kovacs GG; Quadrio I
JAMA Neurol; 2015 Mar; 72(3):267-75. PubMed ID: 25559883
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants.
Abu Rumeileh S; Lattanzio F; Stanzani Maserati M; Rizzi R; Capellari S; Parchi P
J Alzheimers Dis; 2017; 55(4):1471-1480. PubMed ID: 27886009
[TBL] [Abstract][Full Text] [Related]
12. CSF Tau proteins reduce misdiagnosis of sporadic Creutzfeldt-Jakob disease suspected cases with inconclusive 14-3-3 result.
Leitão MJ; Baldeiras I; Almeida MR; Ribeiro MH; Santos AC; Ribeiro M; Tomás J; Rocha S; Santana I; Oliveira CR
J Neurol; 2016 Sep; 263(9):1847-61. PubMed ID: 27357003
[TBL] [Abstract][Full Text] [Related]
13. [CSF-analyses in clinical diagnosis of Creutzfeldt-Jakob disease. A literature review and three cases from routine clinical practice].
Blennow K; Lind B; Andersson E; Andreasen N
Lakartidningen; 2001 May; 98(20):2446-51. PubMed ID: 11433975
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance spectroscopy and measurement of tau epitopes of autopsy proven sporadic Creutzfeldt-Jakob disease in a patient with non-specific initial EEG, MRI and negative 14-3-3 immunoblot.
Sarac H; Hajnsek S; Basić S; Henigsberg N; Rados M; Simić G
Coll Antropol; 2008 Jan; 32 Suppl 1():199-204. PubMed ID: 18405083
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity and specificity evaluation of multiple neurodegenerative proteins for Creutzfeldt-Jakob disease diagnosis using a deep-learning approach.
Lee SM; Hyeon JW; Kim SJ; Kim H; Noh R; Kim S; Lee YS; Kim SY
Prion; 2019 Jan; 13(1):141-150. PubMed ID: 31306078
[TBL] [Abstract][Full Text] [Related]
16. Total and Phosphorylated Cerebrospinal Fluid Tau in the Differential Diagnosis of Sporadic Creutzfeldt-Jakob Disease and Rapidly Progressive Alzheimer's Disease.
Hermann P; Haller P; Goebel S; Bunck T; Schmidt C; Wiltfang J; Zerr I
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215868
[TBL] [Abstract][Full Text] [Related]
17. Additional value of tau protein measurement in the diagnosis of Creutzfeldt-Jakob disease.
Cseh EK; Veres G; Danics K; Szalárdy L; Nánási N; Klivényi P; Vécsei L; Zádori D
Ideggyogy Sz; 2019 Jan; 72(1-2):39-47. PubMed ID: 30785245
[TBL] [Abstract][Full Text] [Related]
18. CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD.
Blennow K; Diaz-Lucena D; Zetterberg H; Villar-Pique A; Karch A; Vidal E; Hermann P; Schmitz M; Ferrer Abizanda I; Zerr I; Llorens F
J Neurol Neurosurg Psychiatry; 2019 Aug; 90(8):846-853. PubMed ID: 31097472
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
Van Everbroeck B; Boons J; Cras P
Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cerebrospinal fluid tau, ptau(181), synuclein, and 14-3-3 for the detection of Creutzfeldt-Jakob disease in clinical practice.
Fayolle M; Lehmann S; Delaby C
J Neural Transm (Vienna); 2022 Feb; 129(2):133-139. PubMed ID: 35041062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]